Evidence map›Paper›PMID 18161878›Full record

ArticleHuman mutation2008

Construction of a multiplex allele-specific PCR-based universal array (ASPUA) and its application to hearing loss screening.

Cai-Xia Li, Qian Pan, Yong-Gang Guo, Yan Li, Hua-Fang Gao, Di Zhang, Hao Hu, Wan-Li Xing, Keith Mitchelson, Kun Xia and 2 more

Abstract read
In one paragraph

Article in Human mutation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A screening analysis of theJournal of otology · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Impact of gene patents and licensing practices on access to genetic testing for hearing loss.Genetics in medicine : official journal of the American College of Medical Genetics · 2010
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cai-Xia LiMedical Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, China.
Qian Pan
Yong-Gang Guo
Yan Li
Hua-Fang Gao
Di Zhang
Hao Hu
Wan-Li Xing
Keith Mitchelson
Kun Xia
Pu Dai
Jing Cheng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We demonstrate a new method, using a universal array approach termed multiplex allele-specific PCR-based universal array (ASPUA), and applied it to the mutation detection of hereditary hearing loss. Mutations in many different genes may be the cause of hereditary hearing loss, a sensory defect disorder. Effective methods for genetic diagnosis are clearly needed to provide clinical management. Owing to the broad genetic basis of this condition, clinical assay of such a highly heterogeneous disorder is expensive and time consuming. In ASPUA, the allele discrimination reaction is carried out in solution by multiplex allele-specific PCR and a universal solid phase array with different tag probes is used to display the PCR result. The purpose of developing the ASPUA platform was to utilize the rapidity and simplicity of the amplification refractory mutation system (ARMS) with the detection power of microarray hybridization. This is the first report of the combination of these two technologies, which allow for the completion of allele-specific detection of 11 of the most frequent mutations causing hereditary hearing loss in under 5 hr. The ASPUA platform was validated by accurately analyzing 141 patient samples that had been previously genotyped for GJB2, GJB3, SLC26A4, and MTRNR1. In addition, we also developed a simplified assay by using streptavidin-coated magnetic beads instead of fluorescence for signal display that can be assessed through a conventional light microscope. We demonstrate that the ASPUA platform is rapid, cost-effective, and easily-used, and is especially appropriate for mutation detection in clinical genetic diagnostics.

Indexed as

AllelesMass ScreeningConnexin 26ConnexinsHearing LossHumansLightMicroarray AnalysisPolymerase Chain ReactionSensitivity and SpecificityConnexin 26ConnexinsGJB2 protein, human

Identifiers

PMID18161878
PMCPMC7165727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.